ABBAS RANA to Waiting Lists
This is a "connection" page, showing publications ABBAS RANA has written about Waiting Lists.
Connection Strength
7.136
-
Constructing an Intent-to-Treat Score Index to Predict Survival Outcomes in Pediatric Liver Transplant Recipients. Pediatr Transplant. 2024 Aug; 28(5):e14816.
Score: 0.801
-
Predicting wait time for pediatric kidney transplant: a novel index. Pediatr Nephrol. 2024 Aug; 39(8):2483-2493.
Score: 0.771
-
Survival on the Heart Transplant Waiting List. JAMA Cardiol. 2020 11 01; 5(11):1227-1235.
Score: 0.618
-
The Transplant Index: A Novel Method to Predict Adult Liver Transplant Waitlist Outcomes. Transplantation. 2019 06; 103(6):1152-1158.
Score: 0.560
-
Waiting list outcomes in pediatric lung transplantation: Poor results for children listed in adult transplant programs. J Heart Lung Transplant. 2017 Nov; 36(11):1201-1208.
Score: 0.484
-
Inferior Outcomes on the Waiting List in Low-Volume Pediatric Heart Transplant Centers. Am J Transplant. 2017 Jun; 17(6):1515-1524.
Score: 0.481
-
Poor outcomes for children on the wait list at low-volume kidney transplant centers in the United States. Pediatr Nephrol. 2017 04; 32(4):669-678.
Score: 0.467
-
Pediatric Liver Transplant Center Volume and the Likelihood of Transplantation. Pediatrics. 2015 Jul; 136(1):e99-e107.
Score: 0.425
-
Is the Transplantation of Elderly and DCD Donors in Low MELD Recipients Justified: An Intent-to-treat Analysis. Transplantation. 2025 05 01; 109(5):823-831.
Score: 0.204
-
Creating a Risk Score for Prolonged Length of Stay Following Pediatric Lung Transplants. Pediatr Pulmonol. 2025 Jan; 60(1):e27397.
Score: 0.204
-
Disparate Intent-to-Treat Outcomes for Pediatric Liver Transplantation Based on Indication. Can J Gastroenterol Hepatol. 2023; 2023:2859384.
Score: 0.181
-
Is Liver Transplant Justified at Any MELD Score? Transplantation. 2023 03 01; 107(3):680-692.
Score: 0.177
-
Trends in Survival for Pediatric Transplantation. Pediatrics. 2022 02 01; 149(2).
Score: 0.168
-
Intent-to-treat survival in liver transplantation has not improved in 3?decades due to donor shortage relative to waitlist growth. Clin Transplant. 2021 10; 35(10):e14433.
Score: 0.163
-
Pediatric discard risk index for predicting pediatric liver allograft discard. Pediatr Transplant. 2021 Aug; 25(5):e13963.
Score: 0.156
-
Pediatric length-of-stay index following liver transplantation. Pediatr Transplant. 2020 11; 24(7):e13779.
Score: 0.152
-
Most pediatric transplant centers are low volume, adult-focused, and in proximity to higher volume pediatric centers. J Pediatr Surg. 2020 Aug; 55(8):1667-1672.
Score: 0.144
-
The decreasing predictive power of MELD in an era of changing etiology of liver disease. Am J Transplant. 2019 12; 19(12):3299-3307.
Score: 0.142
-
The Observer Effect in Liver Transplantation Exemplified by Unintended Consequences of Regulation and Selected Outcome Metrics. Prog Transplant. 2019 09; 29(3):291-292.
Score: 0.140
-
Survival benefit of solid-organ transplant in the United States. JAMA Surg. 2015 Mar 01; 150(3):252-9.
Score: 0.104
-
Geographic inequities in liver allograft supply and demand: does it affect patient outcomes? Transplantation. 2015 Mar; 99(3):515-20.
Score: 0.104
-
Geographic inequity results in disparate mortality: a multivariate intent-to-treat analysis of liver transplant data. Clin Transplant. 2015 Jun; 29(6):484-91.
Score: 0.103
-
A critical analysis of early death after adult liver transplants. Clin Transplant. 2013 Jul-Aug; 27(4):E448-53.
Score: 0.093
-
Impact of COVID-19 Pandemic on Liver Transplantation and Alcohol-Associated Liver Disease in the USA. Hepatology. 2021 12; 74(6):3316-3329.
Score: 0.041
-
Factors Associated With Access to and Receipt of Liver Transplantation in Veterans With End-stage Liver Disease. JAMA Intern Med. 2021 07 01; 181(7):949-959.
Score: 0.040
-
Higher Waitlist Mortality in Pediatric Acute-on-chronic Liver Failure in the UNOS Database. J Pediatr Gastroenterol Nutr. 2021 01 01; 72(1):80-87.
Score: 0.039
-
Liver Transplantation Outcomes in a U.S. Multicenter Cohort of 789 Patients With Hepatocellular Carcinoma Presenting Beyond Milan Criteria. Hepatology. 2020 12; 72(6):2014-2028.
Score: 0.039
-
Donor and transplant candidate selection for solid organ transplantation during the COVID-19 pandemic. Am J Transplant. 2020 11; 20(11):3113-3122.
Score: 0.038
-
Response to "Reply to: 'The decreasing predictive power of MELD in an era of changing etiology of liver disease'". Am J Transplant. 2020 03; 20(3):903-904.
Score: 0.037
-
Time for reform in transplant program-specific reporting: AST/ASTS transplant metrics taskforce. Am J Transplant. 2019 07; 19(7):1888-1895.
Score: 0.035
-
Standing the test of time: outcomes of a decade of prioritizing patients with hepatocellular carcinoma, results of the UNOS natural geographic experiment. Hepatology. 2014 Dec; 60(6):1957-62.
Score: 0.025